Don’t forget about the future: The impact of including future costs on the cost-effectiveness of adult pneumococcal conjugate vaccination with PCV13 in the Netherlands-Reference-Cited by-同舟云学术

Don’t forget about the future: The impact of including future costs on the cost-effectiveness of adult pneumococcal conjugate vaccination with PCV13 in the Netherlands

Published:2021-06 Issue:29 Volume:39 Page:3834-3843
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

de Vries L.M.,Kellerborg K.M.,Brouwer W.B.F.,van Baal P.H.M.

Funder

European Commission

Horizon 2020

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference33 articles.

1. Vaccination greatly reduces disease, disability, death and inequity worldwide;Andre;Bull World Health Organ,2008

2. Methods for the economic evaluation of health care programmes;Drummond,2015

3. When is it too expensive? Cost-effectiveness thresholds and health care decision-making;Brouwer;Eur J Heal Econ,2019

4. Economic Analysis of Vaccination Programs: An ISPOR Good Practices for Outcomes Research Task Force Report;Mauskopf;Value Heal,2018

5. Accounting for future costs in medical cost-effectiveness analysis;Meltzer;J Health Econ,1997

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent changes to adult national immunization programs for pneumococcal vaccination in Europe and how they impact coverage: A systematic review of published and grey literature;Human Vaccines & Immunotherapeutics;2023-11-28

2. Accounting for Nonhealth and Future Costs in Cost-Effectiveness Analysis: Distributional Impacts of a US Cancer Prevention Strategy;PharmacoEconomics;2023-05-17

3. Vaccination in aged patients: breaking barriers. The impact of educational programs;Russian Journal of Geriatric Medicine;2022-12-05

4. Cost effectiveness of PCV13 vaccination in doubt when including future costs and benefits;PharmacoEconomics & Outcomes News;2021-06